Chest Pain Pilot Study

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of Nexium® with placebo in relief of acid related pain or discomfort in the chest.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole

Criteria

Inclusion Criteria:

• Pain or discomfort in the chest without any identifiable cause and severe enough for the patient to seek primary medical or similar care.

• History of pain or discomfort in the chest for at least the last two weeks prior to enrollment.

Exclusion Criteria:

• Signs, symptoms or relevant investigations suggestion present symptomatic coronary heart disease.

• Patients whose pain or discomfort in the chest warrants urgent cardiac investigation.